- Ribociclib Plus Endocrine Therapy in Hormone Receptor–Positive/ ERBB2 -Negative Early Breast Cancer
- Current Controversies and Challenges in Non–Oncogene Addicted Synchronous Oligometastatic Non–Small Cell Lung Cancer
- Limitations in Artificial Intelligence–Driven Patient-Centered Cancer Nursing Research—Reply
- Neoadjuvant Chemoimmunotherapy in Stage III Non–Small Cell Lung Cancer—Reply
- Low-Dose Aspirin for Individualized Cancer Prevention in Older Adults
- Debt, Bankruptcy, and Credit Scores After Cancer Diagnosis
- Limitations in Artificial Intelligence–Driven Patient-Centered Cancer Nursing Research
- JAMA Oncology
- Limitations in Artificial Intelligence–Driven Patient-Centered Cancer Nursing Research
- Rethinking Ribociclib Dosage and Use in the Era of Patient-Centered Oncology
- Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer
- Understanding Lung Cancer in Younger People
- Pembrolizumab Plus Platinum Chemotherapy in Advanced Penile Cancer
- Prostate-Specific Antigen Levels Among Participants Receiving Annual Testing
- AI to Support Modern Cancer Care
